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Long QT syndrome (LQTS) is a genetic-based cause of sud-
den cardiac death. A prolonged QTc interval on electrocar-
diogram (ECG) produces a potentially dangerous substrate
for ventricular tachycardia and syncope or sudden death.1,2
The genetics of LQTS have been well documented over
the past decade, with the identification of more than 15 genes
corresponding to different disease subtypes.3 LQT1, the most
common form, is caused by loss-of-function ofKCNQ1 gene,
which encodes a protein that forms a critical part of a voltage-
gated potassium channel.4 In LQT1 syndrome, syncope or
sudden death is often triggered by emotional or physical
stress such as diving and swimming.2
The locus of KCNQ1 falls within a region of chromo-
some 11p that contains a cluster of genes subjected to
imprinting. Genomic imprinting is the monoallelic
expression of genes, dependent on the parental origin
of the chromosome, which is known to play a vital role
in growth and development. Imprinting disorders origi-
nate from a disturbance in this monoallelic expression
by disruption or epimutation of imprinted genes.5,6 Aber-
rant genomic imprinting of the 11p15 region has a pivotal
role in both Silver Russell syndrome (SRS) and the
Beckwith-Wiedemann syndrome (BWS).7 The molecular
bases of both syndromes are complex and involve the
altered expression of multiple growth regulatory genes
in the 11p15.5 genomic region. The SRS is characterized
by growth failure, typical craniofacial features such
as a prominent forehead and/or triangular face,KEYWORDS Long QT syndrome; Paediatrics; Silver Russell syndrome; Syncope
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BWS is an overgrowth syndrome, the clinical and molec-
ular mirror of SRS.8
Although both LQT1 and SRS loci are in chromosome
11p, this is the first time a child manifesting features of
both syndromes has been described. We describe a patient
with LQT, an SRS phenotype, and a de novo 11p15 duplica-
tion and the investigation into the molecular cause of this
combination of phenotypes.Case report
A 9-year-old girl was referred to the pediatric cardiology
clinic with a murmur. She was a 27-week gestational age pre-
term newborn and her birthweight was 1030 g, which corre-
sponded to a 50th percentile using the Fenton WHO preterm
growth chart (Supplemental Figure S1A). During the first
years of her life, she was diagnosed with postnatal growth
and length restriction falling below 2 standard deviation
(SD) using WHO growth charts (Supplemental Figure S1B
and C) and mild hypercalciuria. Her parents and brother are
healthy and have no apparent phenotype. Moreover, there
were no cases of sudden cardiac death in a 3-generation fam-
ily history.
An SRS diagnosis was established as she met 4 of 6 NH-
CSS criteria.9 She had postnatal growth restriction with low
height, relative macrocephaly at birth, prominent forehead
and a triangular face, and feeding difficulties, with a body
mass index below 2 SD at 24 months. We did not observe
hemihypotrophy or clinodactyly. Her cardiovascular exami-
nation revealed an innocent murmur, and she had a structur-
ally normal heart on echocardiography. However, a 491 ms
QTc interval was observed in the ECG performed during
the visit (Figure 1). No electrolyte disturbances were identi-
fied on initial blood sample analysis. This abnormal QTc
was observed in several subsequent ECGs. Moreover, a
standing test demonstrated a QTc interval of 508 ms at theen access article
.0/).
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KEY TEACHING POINTS
 Silver Russell syndrome (SRS) is characterized by
growth failure, typical craniofacial features such as
a prominent forehead and/or triangular face,
hemihypotrophy, and clinodactyly.
 We describe the first case where a combination of
an imprinting defect and disruption of the KCNQ1
gene can cause the dual phenotype of SRS and long
QT syndrome (LQTS).
 Ventricular arrhythmia risk appears to be similar to
type 1 LQTS and responds well to beta-blocker
therapy.
592 Heart Rhythm Case Reports, Vol 6, No 9, September 2020point of maximal QT-interval stretching and it remained pro-
longed on return to baseline heart rate.
Based on these abnormal findings, the patient was started
on atenolol treatment at 1 mg/kg/day.
Initial genetic testing using next-generation sequencing
and the analysis of single nucleotide variants in 13 genes
associated with LQTS (AKAP9, ANK2, CACNA1C, CAV3,
KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1,
SNC4B, SNC5A, SNTA1) found no pathogenic variants.
Following that result, array comparative genome hybridiza-
tion was performed and a 2.6 Mb duplication was found in
11p15 gene (11:223,538 – 2,849,629, hg37). The duplicationFigure 1 Baseline 12-lead electrocardiograms (ECG) and standing test demons
baseline showed the R-R interval measured in lead II is 713 ms, the QT interval is 4
test measured in V5 showed that the R-R interval is 562 ms, the QT interval is 366 m
up and at the point of maximal QT-interval stretching the R-R interval is 534 ms, the
upright morphology.spanned 87 genes, including imprinting control region 1
(ICR1), the IGF2 and H19 genes, and the long noncoding,
reverse-transcribed RNA, KCNQ1OT1. A schematic over-
view of the 11p15 region, showing the position of the
duplication, is shown in Figure 2A. The duplication was sub-
sequently confirmed and refined to single-exon resolution by
copy number variant analysis on a different targeted next-
generation sequencing gene panel (Trusight Cardio Panel; Il-
lumina, San Diego, CA), containing the KCNQ1 and HRAS
genes. This analysis showed that the duplication breakpoint
disrupts the KCNQ1 gene, with exons 1–12 included in the
duplication (Figure 2B). The inheritance of single nucleotide
polymorphisms within the duplicated 11p15 region was
analyzed to check the parental origin of the patient’s duplica-
tion allele. Single nucleotide polymorphism rs12628 was
informative, showing a skewed allelic balance for the
maternal A allele in the patient (G-to-A ratio of 0.35).
We performed methylation-sensitive multiplex ligation-
dependent probe amplification (Salsa ME030-C3 and
Coffalyser.net; MRC Holland, Amsterdam, Netherlands)10
on DNA from the patient and her parents as well as 6 healthy
control samples, in order to test the methylation status at
ICR1 and ICR2 (Figure 3). The duplication was again clearly
visible (Figure 3A) and methylation analysis showed hypo-
methylation at ICR1 and hypermethylation at ICR2 in the pa-
tient (Figure 3B). This is visible as the decreased percentage
of methylation, from 50% in normal blood and in the pa-
tient’s parents (Figure 3C and D) to an average of 37.75%
in the patient (Figure 3B). Hypermethylation was apparenttrating the point of maximal QT-interval stretching. A: The 12-lead ECG at
15 ms, and the corrected QT interval (QTc) is 491 ms. B1: Baseline standing
s, and the QTc is 488 ms with a negative T wave. B2: The patient then stands
QT interval is 372 ms, and the QTc is 508 ms and the T wave has a different
Figure 2 Schematic overview of the 11p15.5 region (A) and the result of copy number variant analysis after targeted next-generation sequencing (NGS) in the
patient (B). The chromosome 11p15 duplication affecting the HRAS and KCNQ1 genes, these being the only 11p15 genes on the targeted NGS panel, together
with the duplication breakpoint in intron 12 are shown.
Roses-Noguer et al Long QT and Silver Russell Syndrome: Case Report 593at ICR2, with an average of 72% methylation across the 4
probes in the patient (Figure 3B), as opposed to the normal
50% methylation shown in her parents (Figure 3C and D).
Hypomethylation in the patient at ICR1 was further illus-
trated when the mean of the methylation ratios across 4
ICR1 probes in the control samples (SD 0.03) was
compared with the values in the patient (Figure 3E). Despite
the relatively low statistical power owing to the small sample
number, if one assumes a normal distribution of the control
values, the difference between the control and patient values
is highly significant (SD .5, P 510e-6).
A loss-of-function of the KCNQ1 gene, caused by the
duplication breakpoint interrupting the gene, is consistent
with the patient’s phenotype on ECG. After that result, the
patient was switched to nadolol owing to atenolol intoler-
ance. No cardiac events have been reported during her
follow-up. She was subsequently admitted to the emergency
department presenting with syncope due to hypoglycemia.
However, an implantable loop recorder was implanted to
assist further monitoring as there were potentially multiple
reasons for syncope/collapse. After 25 months follow-up
the patient has had no other cardiac events and the implant-
able loop recorder remote monitoring has shown no cardiac
arrhythmias.Discussion
The 11p15 duplication spans one of the best-known, but most
complex, imprinted regions in the genome. The imprinted11p15 region is organized in 2 domains, each of them under
the control of its own ICR: ICR1 for the IGF2/H19 domain
and ICR2 for the KCNQ1OT1/CDKN1C domain.11 The telo-
meric ICR1 confers a differential chromatin structure to the
2 parental alleles. leading to a reciprocal expression of H19
and IGF2.12 The centromeric ICR2 is maternally methylated
and controls the monoallelic silencing of the noncoding anti-
sense transcript KCNQ1OT1, as well as the monoallelic
expression of CDKN1C and KCNQ1 in an as-yet-unknown
manner.12 This region, when subject to various types of mu-
tation, including both genetic and epigenetic abnormalities,
and depending on the parental inheritance, can be responsible
for either BWS or SRS.5 The most common cause of SRS
(approximately 40% of cases) is hypomethylation of the
ICR1. However, the exact mechanisms leading to ICR1 hy-
pomethylation remain unknown. Uniparental disomy for
chromosome 7 is the next most common cause of SRS
(10% of patients). Duplications and other rearrangements
are responsible for only 1%–2% of cases.13 Our findings sug-
gest that the de novo duplication on 11p15 on the maternal
allele in our patient alters the methylation at both ICR1 and
ICR2, thus causing the observed SRS phenotype.
At least 15 patients with duplications on 11p15 as the
cause of an SRS-like syndrome have been described, with du-
plications ranging from 1.6 to 10Mb 12. Although at least two
of these duplications appear to interrupt the KCNQ1
gene.11,14 LQTS has not been reported in these patients.
The KCNQ1 imprinted domain exhibits complex tissue-
specific expression patterns at different stages of
Figure 3 Methylation-sensitive multiplex ligation-dependent probe amplification (MLPA) analysis on chromosome 11p15 in the patient and her parents. A:
Copy numberMLPA showing the duplication on 11p15 in the patient (purple dots), spanning theH19, IGFR2,KCNQ1,KCNQ1OT1, andCDKN1C genes.B–D:
Methylation MLPA in the patient (B) and her parents (C, D), showing the altered methylation status at imprinting control region (ICR) 1 and ICR2 in the patient,
with hypomethylation at ICR1 and hypermethylation at ICR2 (purple arrows), and normal methylation patterns in her mother (C) and father (D).E:Meanmethyl-
ation ratios in 6 healthy controls and the patient’s parents (SD 0.03 for the 8 samples) plotted with the methylation ratios in the patient for ICR1. The reduced
methylation at ICR1 in the patient was significantly different from that in the controls (.5 SD for all values,P, 10e-6). Lanes: 1: NSD1-21, 2: NSD1-23, 3: H19-
5, 4: H19-1, 5-6: H19-1 (HhaI), 7-8: H19-up (HhaI), 9-11: H19-up, 12: IGH2-7, 13: IGH2-4 (HhaI), 14: KCNQ1-2, 15: KCNQ1-3, 16: KCNQ1-7, 17: KCNQ1-8,
18: KCNQ1-9, 19-22: KCNQ1OT1-1-ICR (HhaI), 23: KCNQ1-13, 24: KCNQ1-15, 25: KCNQ1-17, 26: CDKN1C-3, 27: CDKN1C-1, 28: CDKN1C-1 (HhaI),
29: ESCO2-1 (HhaI), 30–42: Reference C/M*.
594 Heart Rhythm Case Reports, Vol 6, No 9, September 2020development. The antisense noncoding RNA, KCNQ1OT1,
is transcribed from the paternal allele, emerging from intron
11 of KCNQ1 in an antisense direction. Experiments in mice
have demonstrated that transcription of the paternally ex-
pressed KCNQ1OT1 silences some neighboring genes in
the embryo, while others are unaffected.15 KCNQ1 is im-
printed andmaternally expressed during early embryogenesis
and transitions to biallelic expression in a tissue-specific
manner. In the embryonic mouse heart, the transition to bial-
lelic expression occurs at approximately E14.5 and appears
to be quite consistent.15 The epigenetic profile of KCNQ1
expression during human cardiac development, however,
has not yet been fully elucidated, and may well play a role
in the extensive phenotypic variability shown in the expres-
sion of LQTS.15
In our patient, the duplication breakpoint is located in
intron 12 of KCNQ1, and therefore disrupts KCNQ1, pre-
dicted to cause loss-of-function and the QTc prolongation.
Interestingly, there are no reports in the literature of theoccurrence of LQT accompanying SRS, but it is assumed
that most of the SRS-causative defects do not disrupt the
KCNQ1 gene. The only cardiac defects reported in SRS
were bicuspid aortic valve, subaortic stenosis, and ventricular
septal defect. Until recently, there was a single report of a pa-
tient with mild BWS, an inherited maternal deletion in
KCNQ1, affecting ICR2, and severe long QT.16 The mother
of the patient described in that paper (56-year-old woman)
had no history of syncope attacks or palpitation and her Hol-
ter monitoring did not reveal any significant arrhythmia. She
had a deletion on her paternal chromosome 11, SRS-like
symptoms, and mild QT prolongation (QTc 463 ms) with
flat T waves in V2–V3.More recently, an additional 3 patients
were reported with both BWS and LQTS, with predicted
KCNQ1 haploinsufficiency and loss of methylation of
IC2.6 We therefore propose that the combination of an
imprinting defect and disruption of the KCNQ1 gene on the
maternal allele in our patient has caused the dual phenotype
of SRS and LQTS. We believe this is the first time the 2
Roses-Noguer et al Long QT and Silver Russell Syndrome: Case Report 595syndromes have been described together but think this
finding is important to raise awareness of the potential for
LQTS in patients with SRS and BWS.
Appendix
Supplementary data
Supplementary data associated with this article can be found
in the online version at https://doi.org/10.1016/j.hrcr.2020.
06.003.
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